Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$75.27
-0.3%
$79.82
$51.79
$101.40
$10.22B0.951.49 million shs419,377 shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$49.63
-1.5%
$44.89
$38.91
$147.03
$1.43B0.711.18 million shs165,098 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$316.23
-0.1%
$319.64
$221.26
$362.41
$12.44B0.7705,243 shs183,712 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
-0.67%-3.90%-4.52%-20.12%+42.22%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-3.95%+0.14%+21.25%-10.35%-61.08%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.26%-0.12%+0.03%-5.03%+36.30%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$75.27
-0.3%
$79.82
$51.79
$101.40
$10.22B0.951.49 million shs419,377 shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$49.63
-1.5%
$44.89
$38.91
$147.03
$1.43B0.711.18 million shs165,098 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$316.23
-0.1%
$319.64
$221.26
$362.41
$12.44B0.7705,243 shs183,712 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
-0.67%-3.90%-4.52%-20.12%+42.22%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-3.95%+0.14%+21.25%-10.35%-61.08%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.26%-0.12%+0.03%-5.03%+36.30%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.81
Moderate Buy$103.7538.55% Upside
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.19
Hold$74.8352.13% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.11
Hold$360.3313.87% Upside

Current Analyst Ratings Breakdown

Latest GMED, INSP, and PEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Reiterated RatingHold (C)
7/16/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetBuy$115.00 ➝ $100.00
7/16/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Boost Price TargetHold$50.00 ➝ $54.00
7/13/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Reiterated RatingHold (C+)
7/13/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetOutperform$120.00 ➝ $115.00
7/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Initiated CoverageOutperform$94.00
7/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
UpgradeStrong-Buy
7/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetHold$95.00 ➝ $80.00
7/6/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Reiterated RatingOutperform$320.00
7/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
DowngradeStrong-BuyHold
7/6/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
UpgradeStrong SellHold
(Data available from 7/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.94B3.46$6.18 per share12.11$33.86 per share2.21
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M1.55$2.68 per share18.33$26.88 per share1.83
Penumbra, Inc. stock logo
PEN
Penumbra
$1.45B8.56$4.29 per share73.83$36.45 per share8.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$4.3017.4214.861.5718.92%13.46%11.65%8/6/2026 (Estimated)
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.4910.9537.275.3114.33%10.35%8.81%8/3/2026 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$4.3472.9250.961.9711.76%10.87%8.45%8/4/2026 (Estimated)

Latest GMED, INSP, and PEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.12N/AN/AN/A$782.82 millionN/A
8/4/2026Q2 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.15N/AN/AN/A$389.64 millionN/A
8/3/2026Q2 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.22N/AN/AN/A$194.75 millionN/A
5/7/2026Q1 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.92$1.12+$0.20$0.90$740.35 million$759.85 million
5/6/2026Q1 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.06$0.82-$0.24$0.82$370.47 million$374.76 million
5/4/2026Q1 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2753$0.10+$0.3753-$0.39$200.04 million$204.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.56
2.95
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
6.34
4.48
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
6.02
3.95

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000135.74 million110.80 millionOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.81 million28.18 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.33 million38.19 millionOptionable

Recent News About These Companies

Hsbc Holdings PLC Boosts Holdings in Penumbra, Inc. $PEN
Penumbra, Inc. $PEN Shares Acquired by Fifth Third Bancorp

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Globus Medical stock logo

Globus Medical NYSE:GMED

$75.27 -0.23 (-0.30%)
As of 12:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$49.63 -0.77 (-1.53%)
As of 12:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Penumbra stock logo

Penumbra NYSE:PEN

$316.23 -0.28 (-0.09%)
As of 12:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.